Contrast Media Injectors Market by Product (System (CT, MRI, Angiography, Mammo), Consumable, Accessories), Type (Single & Dual-head, Syringeless), Application (General Imaging, Interventional), End user (Hospital, Clinic), & Region - Global Forecast to 2029
The global contrast media injectors market is expected to reach USD 2.3 billion by 2029 from USD 1.6 billion in 2024, at a CAGR of 8.0% from 2024 to 2029. Aging population, coupled with a rise in cancer and heart diseases, has increased the demand for these products. Cardiovascular diseases are more prevalent in old-age population. Contrast media helps to better visualize the blood vessels and improves diagnostic confidence. Moreover, increased benefits of contrast-mediated procedures have driven demand for contrast media injectors.
“The consumables segment of product segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like – syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.
“The dual-head injector segment of type segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.
“The radiology segment for application segment to hold the largest market share in 2023”.
Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.
“The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
“The consumables segment of product segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on product into injector systems, consumables, and accessories. Contrast media consumables, like – syringes, tubing, vials and bottles, IV sets, etc., are the various products used to administer contrast agents for imaging procedures. The rising prevalence of chronic diseases and the growing demand for early diagnosis have led to an increase in diagnostic imaging procedures, boosting the demand for contrast media consumables.
“The dual-head injector segment of type segment held the largest share of the market in 2023”
The contrast media injectors market is segmented based on type into dual-head, single head, syringeless. The rising prevalence of heart diseases and growing opportunities in emerging countries drives this segment. There are number of companies providing contrast media injectors and consumables in China. Focus on innovation and strategies adopted by these players to expand their geographic presence offers lucrative opportunity for the growth of overall market. Dual-head injectors have notable benefits such as improved workflow efficiency and enhanced safety. The launch of new dual-head injectors in past few years has supported its adoption in end user facilities.
“The radiology segment for application segment to hold the largest market share in 2023”.
Based on application, the contrast media injectors market is segmented into interventional radiology, interventional cardiology, and radiology. Radiology was the major segment, accounting for the largest contrast media injectors market share in 2023. The rising incidence of chronic conditions is supported by the increasing aging population. This ultimately drives the adoption of contrast media injectors. A rising number of campaigns for the early detection of symptoms is also contributing to the increasing number of diagnostic imaging scans that ultimately support the adoption of contrast media injectors in end-user facilities.
“The diagnostic imaging centers segment for the end user segment is projected to register a significant CAGR during the forecast period.”
The contrast media injectors market is segmented by end-users into hospitals and diagnostic imaging centers. The hospitals accounted for a major end-user market share in 2023. The emphasis on minimally invasive treatment among the old-age population and increasing grants for the installation of advanced imaging equipment are driving the integration of contrast media injectors into hospital settings. Rising number of diagnostic imaging centers to fulfill the growing demand for imaging equipment and consistent rise in old-age population is expected to support the growth of this segment.
“The market in the Asia Pacific region is expected to witness the highest growth during the forecast period.”
Increased investment in healthcare infrastructure and services, especially in emerging economies, supports the expansion of diagnostic imaging and, consequently, the demand for contrast injectors. Key players in the market are focusing on expanding their presence in Asia Pacific market to cater the increasing demand for diagnostic scans. Moreover, the proliferation of diagnostic centers, particularly in APAC region, increases the availability and accessibility of imaging services, further driving the demand for contrast media injectors.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1–30%, Tier 2–42%, and Tier 3– 28%
- By Designation: Director-level–10%, C-level–14%, and Others–76%
- By Region: North America–40%, Europe–30%, Asia Pacific–22%, Latin America–6%, and the Middle East & Africa–2%
Research Coverage
This report studies the contrast media injectors market based on product, application, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will help market leaders and new entrants with information on the closest approximations of the revenue numbers for the overall contrast media injectors market and the subsegments. It will also help stakeholders understand the competitive landscape and gain more insights to better position their businesses and plan suitable go-to-market strategies. The report also helps stakeholders understand the market pulse and provides information on key market drivers, restraints, challenges, and opportunities.
This report provides insights on the following pointers:
- Analysis of key drivers (increasing prevalence of cancer and cardiovascular diseases, growing adoption of contrast-mediated CT and MRI procedures, growing approvals of contrast media), restraints (high cost of contrast media injectors systems), opportunities (rising healthcare expenditure across emerging countries), and challenges (dearth of trained professionals) influencing the growth of the contrast media injectors market
- Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the contrast media injectors market
- Market Development: Comprehensive information about lucrative markets–the report analyses the contrast media injectors market across varied regions.
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the contrast media injectors market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players, such as Bayer AG (Germany), Guerbet (France), Bracco Imaging S.p.A. (Italy), Ulrich GmbH & Co. Kg (Germany), Medtron AG (Germany), and Nemoto Kyorindo (Japan).
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.2.1.2 Approach 2: Customer-based market estimation
FIGURE 6 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
2.3 DATA TRIANGULATION METHODOLOGY
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 MARKET SHARE ASSESSMENT
2.5.1 STUDY ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 10 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 11 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 12 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 13 GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET
4 PREMIUM INSIGHTS
4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW
FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET
4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of cancer and cardiovascular diseases
FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION)
TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040
5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures
TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019?2021
TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019?2021
5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors
5.2.1.4 Favorable reimbursements in developed markets
5.2.2 RESTRAINTS
5.2.2.1 High cost of contrast media injectors
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging economies
5.2.3.2 Growing focus on mammography and nuclear imaging injectors
5.2.3.3 IT-enabled injector solutions
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals and limited technical expertise
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & DEVELOPMENT
5.3.2 MANUFACTURING & ASSEMBLY
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 21 CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 PROMINENT COMPANIES
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.4.3 END USERS
FIGURE 22 CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS
TABLE 5 CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM
5.6 REGULATORY ANALYSIS
TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY
5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.1 North America: Regulatory bodies and government agencies
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.2 Europe: Regulatory bodies and government agencies
TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.3 Asia Pacific: Regulatory bodies and government agencies
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.4 Latin America: Regulatory bodies and government agencies
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies
TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.2 REGULATORY GUIDELINES
5.6.2.1 US
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.6.2.2 Canada
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2.3 Europe
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2.4 Asia Pacific
5.6.2.4.1 Japan
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.6.2.4.2 China
TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.2.4.3 India
5.6.2.4.4 Brazil
5.7 REIMBURSEMENT SCENARIO
TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023
5.8 INVESTMENT & FUNDING SCENARIO
FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018?2022 (USD MILLION)
FIGURE 28 NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022
FIGURE 29 VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
5.9 PRICING ANALYSIS
FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY PRODUCT
FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION
TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION
5.10 TRADE ANALYSIS
TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.11 PATENT ANALYSIS
FIGURE 32 PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013–2023)
5.12 PORTER’S FIVE FORCE ANALYSIS
TABLE 21 PORTER’S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024–2025
5.14 CASE STUDY ANALYSIS
TABLE 23 CASE STUDY 1: CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 MRI contrast media injectors
5.15.1.2 CT contrast media injectors
5.15.1.3 Angiography contrast media injectors
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Diagnostic imaging modalities
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 Artificial intelligence with automated data systems
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET
5.17 KEY STAKEHOLDERS & BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FIGURE 35 BUYING CRITERIA FOR END USERS
TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS
FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER
TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER
5.17.2 BUYING CRITERIA
FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS
TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS
5.18 UNMET NEEDS & KEY PAIN POINTS
TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS
5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET
6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 29 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.2 INJECTOR SYSTEMS
TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1 CT INJECTORS
6.2.1.1 Increasing number of CT scans to boost demand
TABLE 32 CT INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.2 MRI INJECTORS
6.2.2.1 Rising funding initiatives for development of advanced systems to propel market
TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.3 ANGIOGRAPHY INJECTORS
6.2.3.1 High uptake of cardiac catheterization procedures to drive market
TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.4 OTHER INJECTORS
6.3 CONSUMABLES
TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.1 SYRINGES
6.3.1.1 Diverse size range to fuel uptake
TABLE 37 SYRINGES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.2 TUBES
6.3.2.1 Increasing demand for single-use products to drive market
TABLE 38 TUBES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.3 OTHER CONSUMABLES
TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4 ACCESSORIES
6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH
TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 41 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.2 SINGLE-HEAD INJECTORS
7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET
TABLE 42 CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
7.3 DUAL-HEAD INJECTORS
7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND
TABLE 43 CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
7.4 SYRINGELESS INJECTORS
7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH
TABLE 44 CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022–2029 (USD MILLION)
8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 45 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
8.2 RADIOLOGY
8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET
TABLE 46 CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION, 2022–2029 (USD MILLION)
8.3 INTERVENTIONAL CARDIOLOGY
8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET
TABLE 47 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022–2029 (USD MILLION)
8.4 INTERVENTIONAL RADIOLOGY
8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 48 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022–2029 (USD MILLION)
9 CONTRAST MEDIA INJECTORS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 49 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2 HOSPITALS
9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH
TABLE 50 CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
9.3 DIAGNOSTIC IMAGING CENTERS
9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
TABLE 51 CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION)
10 CONTRAST MEDIA INJECTORS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 52 CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
TABLE 53 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Rising adoption of technologically advanced products to drive market
TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising investments in medical imaging equipment to drive market
TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 69 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Advancements in imaging technologies to fuel uptake
TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing prevalence of cancer to propel market
TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.4 UK
10.3.4.1 High incidence of CVD to propel market
TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Rising incidence of chronic diseases to support market growth
TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Shortage of skilled radiologists to restrain market
TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
TABLE 90 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 93 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market
TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand
TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Growing investments in radiology to propel market
TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market
TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth
TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5 LATIN AMERICA
TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 118 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market
TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Inadequate healthcare infrastructure to restrain market
TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET
TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
11.3 REVENUE ANALYSIS
FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019?2023)
11.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
TABLE 135 CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION
11.4.1 RANKING OF KEY MARKET PLAYERS
FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 43 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
FIGURE 44 CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT
11.5.5.2 Product footprint
TABLE 136 CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT
11.5.5.3 Application footprint
TABLE 137 CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT
11.5.5.4 End-user footprint
TABLE 138 CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT
11.5.5.5 Region footprint
TABLE 139 CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 45 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 140 CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 141 CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
FIGURE 46 EV/EBITDA OF KEY VENDORS
11.7.2 COMPANY VALUATION
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 48 CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 142 CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
11.9.2 DEALS
TABLE 143 CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021–MAY 2024
11.9.3 EXPANSIONS
TABLE 144 CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*
12.1.1 BAYER AG
TABLE 145 BAYER AG: COMPANY OVERVIEW
FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023)
TABLE 146 BAYER AG: PRODUCTS OFFERED
TABLE 147 BAYER AG: DEALS, JANUARY 2021?MAY 2024
12.1.2 BRACCO IMAGING S.P.A.
TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021?MAY 2024
TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021?MAY 2024
12.1.3 GUERBET
TABLE 152 GUERBET: COMPANY OVERVIEW
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023)
TABLE 153 GUERBET: PRODUCTS OFFERED
TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021?MAY 2024
12.1.4 ULRICH GMBH & CO. KG
TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW
TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED
TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021?MAY 2024
12.1.5 MEDTRON AG
TABLE 158 MEDTRON AG.: COMPANY OVERVIEW
TABLE 159 MEDTRON AG: PRODUCTS OFFERED
TABLE 160 MEDTRON AG: DEALS, JANUARY 2021?MAY 2024
12.1.6 NEMOTO KYORINDO CO., LTD.
TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW
TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED
12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD.
TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW
TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED
12.1.8 SINO MDT
TABLE 165 SINO MDT: COMPANY OVERVIEW
TABLE 166 SINO MDT: PRODUCTS OFFERED
12.1.9 APOLLO RT CO., LTD.
TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW
TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED
12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW
TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED
12.1.11 SHENZHEN ANTMED CO., LTD.
TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW
TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED
12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
12.1.13 UNION MEDICAL SHENZHEN CO., LTD.
TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW
TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED
12.1.14 SPECTRUM MEDICAL TECHNOLOGIES
TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW
TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED
12.2 OTHER PLAYERS
12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW
12.2.2 VYGON: COMPANY OVERVIEW
12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW
12.2.4 LEMER PAX: COMPANY OVERVIEW
12.2.5 COMECER S.P.A.: COMPANY OVERVIEW
12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW
12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW
12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW
12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 STAKEHOLDERS
1.5 SUMMARY OF CHANGES
1.6 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY RESEARCH
2.1.2 PRIMARY RESEARCH
2.1.2.1 Primary sources
2.1.2.2 Key industry insights
2.1.2.3 Breakdown of primaries
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 BOTTOM-UP APPROACH
2.2.1.1 Approach 1: Company revenue estimation approach
FIGURE 5 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ESTIMATION)
2.2.1.2 Approach 2: Customer-based market estimation
FIGURE 6 CONTRAST MEDIA INJECTORS MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH
2.2.1.3 Growth forecast
2.2.1.4 CAGR projections
FIGURE 7 CAGR PROJECTION: SUPPLY-SIDE ANALYSIS
2.3 DATA TRIANGULATION METHODOLOGY
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 RESEARCH LIMITATIONS
2.5 MARKET SHARE ASSESSMENT
2.5.1 STUDY ASSUMPTIONS
2.5.2 GROWTH RATE ASSUMPTIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT ANALYSIS
2.7 RECESSION IMPACT ANALYSIS
3 EXECUTIVE SUMMARY
FIGURE 9 CONTRAST MEDIA INJECTORS MARKET, PRODUCT, 2024 VS. 2029 (USD MILLION)
FIGURE 10 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION)
FIGURE 11 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 12 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 13 GEOGRAPHIC SNAPSHOT OF CONTRAST MEDIA INJECTORS MARKET
4 PREMIUM INSIGHTS
4.1 CONTRAST MEDIA INJECTORS MARKET OVERVIEW
FIGURE 14 GROWING ADOPTION OF CONTRAST-MEDIATED CT AND MRI DIAGNOSTIC PROCEDURES TO DRIVE MARKET
4.2 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT AND COUNTRY (2023)
FIGURE 15 CONSUMABLES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN US (2023)
4.3 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION)
FIGURE 16 INTERVENTIONAL CARDIOLOGY SEGMENT TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2024 VS. 2029 (USD MILLION)
FIGURE 17 DIAGNOSTIC IMAGING CENTERS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
4.5 CONTRAST MEDIA INJECTORS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 18 EMERGING MARKETS PROJECTED TO REACH HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 19 CONTRAST MEDIA INJECTORS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
5.2.1 DRIVERS
5.2.1.1 Rising incidence of cancer and cardiovascular diseases
FIGURE 20 NEWLY DIAGNOSED CANCER CASES (MILLION)
TABLE 2 PROJECTED INCREASE IN GLOBAL NUMBER OF CANCER PATIENTS, 2020 VS. 2030 VS. 2040
5.2.1.2 Increasing volume of contrast-mediated MRI and CT procedures
TABLE 3 NUMBER OF MRI EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019?2021
TABLE 4 NUMBER OF CT EXAMS PERFORMED PER 1,000 INHABITANTS, BY COUNTRY, 2019?2021
5.2.1.3 Growing approvals for CT and MRI contrast media to fuel demand for injectors
5.2.1.4 Favorable reimbursements in developed markets
5.2.2 RESTRAINTS
5.2.2.1 High cost of contrast media injectors
5.2.3 OPPORTUNITIES
5.2.3.1 High growth potential of emerging economies
5.2.3.2 Growing focus on mammography and nuclear imaging injectors
5.2.3.3 IT-enabled injector solutions
5.2.4 CHALLENGES
5.2.4.1 Shortage of skilled professionals and limited technical expertise
5.3 VALUE CHAIN ANALYSIS
5.3.1 RESEARCH & DEVELOPMENT
5.3.2 MANUFACTURING & ASSEMBLY
5.3.3 DISTRIBUTION, MARKETING & SALES, AND POST-SALES SERVICES
FIGURE 21 CONTRAST MEDIA INJECTORS MARKET: VALUE CHAIN ANALYSIS
5.4 SUPPLY CHAIN ANALYSIS
5.4.1 PROMINENT COMPANIES
5.4.2 SMALL AND MEDIUM-SIZED ENTERPRISES
5.4.3 END USERS
FIGURE 22 CONTRAST MEDIA INJECTORS MARKET: SUPPLY CHAIN ANALYSIS
5.5 ECOSYSTEM ANALYSIS
FIGURE 23 PARENT MARKET: ECOSYSTEM ANALYSIS
TABLE 5 CONTRAST MEDIA INJECTORS MARKET: ROLE IN ECOSYSTEM
5.6 REGULATORY ANALYSIS
TABLE 6 REGULATORY APPROVALS REQUIRED FOR CONTRAST MEDIA INJECTORS, BY COUNTRY
5.6.1 REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.1 North America: Regulatory bodies and government agencies
TABLE 7 NORTH AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.2 Europe: Regulatory bodies and government agencies
TABLE 8 EUROPE: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.3 Asia Pacific: Regulatory bodies and government agencies
TABLE 9 ASIA PACIFIC: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.4 Latin America: Regulatory bodies and government agencies
TABLE 10 LATIN AMERICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.1.5 Middle East & Africa: Regulatory bodies and government agencies
TABLE 11 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES AND GOVERNMENT AGENCIES
5.6.2 REGULATORY GUIDELINES
5.6.2.1 US
TABLE 12 US FDA: MEDICAL DEVICE CLASSIFICATION
TABLE 13 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 24 PREMARKET NOTIFICATION: 510(K) APPROVALS FOR MEDICAL DEVICES
5.6.2.2 Canada
TABLE 14 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS
FIGURE 25 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2.3 Europe
FIGURE 26 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES
5.6.2.4 Asia Pacific
5.6.2.4.1 Japan
TABLE 15 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PHARMACEUTICAL AND MEDICAL DEVICE AGENCY (PMDA)
5.6.2.4.2 China
TABLE 16 CHINA: CLASSIFICATION OF MEDICAL DEVICES
5.6.2.4.3 India
5.6.2.4.4 Brazil
5.7 REIMBURSEMENT SCENARIO
TABLE 17 MEDICAL REIMBURSEMENT CODES FOR CONTRAST MEDIA IN US, 2023
5.8 INVESTMENT & FUNDING SCENARIO
FIGURE 27 NUMBER OF DEALS & FUNDING INITIATIVES IN CONTRAST MEDIA INJECTORS MARKET, 2018?2022 (USD MILLION)
FIGURE 28 NUMBER OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022
FIGURE 29 VALUE OF INVESTOR DEALS IN CONTRAST MEDIA INJECTORS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
5.9 PRICING ANALYSIS
FIGURE 30 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY PRODUCT
FIGURE 31 AVERAGE SELLING PRICE TREND OF CONTRAST MEDIA INJECTORS, BY REGION
TABLE 18 AVERAGE SELLING PRICE OF CONTRAST MEDIA INJECTORS, BY REGION
5.10 TRADE ANALYSIS
TABLE 19 IMPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2019–2023 (USD THOUSAND)
TABLE 20 EXPORT DATA FOR CONTRAST MEDIA INJECTORS (HS CODE 9018), BY COUNTRY, 2018–2022 (USD THOUSAND)
5.11 PATENT ANALYSIS
FIGURE 32 PATENT ANALYSIS: CONTRAST MEDIA INJECTORS MARKET (2013–2023)
5.12 PORTER’S FIVE FORCE ANALYSIS
TABLE 21 PORTER’S FIVE FORCES ANALYSIS: CONTRAST MEDIA INJECTORS MARKET
5.12.1 THREAT OF NEW ENTRANTS
5.12.2 THREAT OF SUBSTITUTES
5.12.3 BARGAINING POWER OF SUPPLIERS
5.12.4 BARGAINING POWER OF BUYERS
5.12.5 INTENSITY OF COMPETITIVE RIVALRY
5.13 KEY CONFERENCES & EVENTS IN 2024–2025
TABLE 22 LIST OF MAJOR CONFERENCES & EVENTS IN CONTRAST MEDIA INJECTORS MARKET, 2024–2025
5.14 CASE STUDY ANALYSIS
TABLE 23 CASE STUDY 1: CARDIAC ENHANCEMENT ANALYSIS VIA CONTRAST MEDIA INJECTORS
5.15 TECHNOLOGY ANALYSIS
5.15.1 KEY TECHNOLOGIES
5.15.1.1 MRI contrast media injectors
5.15.1.2 CT contrast media injectors
5.15.1.3 Angiography contrast media injectors
5.15.2 COMPLEMENTARY TECHNOLOGIES
5.15.2.1 Diagnostic imaging modalities
5.15.3 ADJACENT TECHNOLOGIES
5.15.3.1 Artificial intelligence with automated data systems
5.16 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
FIGURE 33 REVENUE SHIFT IN CONTRAST MEDIA INJECTORS MARKET
5.17 KEY STAKEHOLDERS & BUYING CRITERIA
5.17.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 34 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR PRIMARY FACTORS
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS
FIGURE 35 BUYING CRITERIA FOR END USERS
TABLE 25 INFLUENCE OF END USERS ON BUYING PROCESS
FIGURE 36 INFLUENCE OF STAKEHOLDERS. BY END USER
TABLE 26 INFLUENCE OF STAKEHOLDERS, BY END USER
5.17.2 BUYING CRITERIA
FIGURE 37 KEY BUYING CRITERIA FOR PROCESS CONTRAST MEDIA INJECTORS
TABLE 27 KEY BUYING CRITERIA FOR CONTRAST MEDIA INJECTORS
5.18 UNMET NEEDS & KEY PAIN POINTS
TABLE 28 CONTRAST MEDIA INJECTORS MARKET: CURRENT UNMET NEEDS
5.19 ARTIFICIAL INTELLIGENCE (AI) IN CONTRAST MEDIA INJECTORS MARKET
6 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT
6.1 INTRODUCTION
TABLE 29 CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
6.2 INJECTOR SYSTEMS
TABLE 30 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 31 CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.1 CT INJECTORS
6.2.1.1 Increasing number of CT scans to boost demand
TABLE 32 CT INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.2 MRI INJECTORS
6.2.2.1 Rising funding initiatives for development of advanced systems to propel market
TABLE 33 MRI INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.3 ANGIOGRAPHY INJECTORS
6.2.3.1 High uptake of cardiac catheterization procedures to drive market
TABLE 34 ANGIOGRAPHY INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
6.2.4 OTHER INJECTORS
6.3 CONSUMABLES
TABLE 35 CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 36 CONTRAST MEDIA CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.1 SYRINGES
6.3.1.1 Diverse size range to fuel uptake
TABLE 37 SYRINGES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.2 TUBES
6.3.2.1 Increasing demand for single-use products to drive market
TABLE 38 TUBES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.3.3 OTHER CONSUMABLES
TABLE 39 OTHER CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
6.4 ACCESSORIES
6.4.1 ABILITY TO ENHANCE WORKFLOW EFFICIENCY TO SUPPORT MARKET GROWTH
TABLE 40 CONTRAST MEDIA ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION)
7 CONTRAST MEDIA INJECTORS MARKET, BY TYPE
7.1 INTRODUCTION
TABLE 41 CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
7.2 SINGLE-HEAD INJECTORS
7.2.1 COST-EFFICIENT AND USER-FRIENDLY DESIGN TO PROPEL MARKET
TABLE 42 CONTRAST MEDIA INJECTORS MARKET FOR SINGLE-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
7.3 DUAL-HEAD INJECTORS
7.3.1 PRECISE CONTROL AND ENHANCED PATIENT SAFETY TO BOOST DEMAND
TABLE 43 CONTRAST MEDIA INJECTORS MARKET FOR DUAL-HEAD INJECTORS, BY REGION, 2022–2029 (USD MILLION)
7.4 SYRINGELESS INJECTORS
7.4.1 DIRECT ADMINISTRATION VIA TUBING TO SUPPORT MARKET GROWTH
TABLE 44 CONTRAST MEDIA INJECTORS MARKET FOR SYRINGELESS INJECTORS, BY REGION, 2022–2029 (USD MILLION)
8 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION
8.1 INTRODUCTION
TABLE 45 CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
8.2 RADIOLOGY
8.2.1 RISING NUMBER OF RADIOLOGY PROCEDURES TO DRIVE MARKET
TABLE 46 CONTRAST MEDIA INJECTORS MARKET FOR RADIOLOGY, BY REGION, 2022–2029 (USD MILLION)
8.3 INTERVENTIONAL CARDIOLOGY
8.3.1 RISING UPTAKE OF CORONARY CT ANGIOGRAMS TO PROPEL MARKET
TABLE 47 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL CARDIOLOGY, BY REGION, 2022–2029 (USD MILLION)
8.4 INTERVENTIONAL RADIOLOGY
8.4.1 INCREASING PREFERENCE FOR MINIMALLY INVASIVE PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 48 CONTRAST MEDIA INJECTORS MARKET FOR INTERVENTIONAL RADIOLOGY, BY REGION, 2022–2029 (USD MILLION)
9 CONTRAST MEDIA INJECTORS MARKET, BY END USER
9.1 INTRODUCTION
TABLE 49 CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
9.2 HOSPITALS
9.2.1 HIGH PURCHASING POWER FOR ADVANCED EQUIPMENT TO SUPPORT MARKET GROWTH
TABLE 50 CONTRAST MEDIA INJECTORS MARKET FOR HOSPITALS, BY REGION, 2022–2029 (USD MILLION)
9.3 DIAGNOSTIC IMAGING CENTERS
9.3.1 INCREASING ESTABLISHMENT OF PRIVATE IMAGING CENTERS TO PROPEL MARKET
TABLE 51 CONTRAST MEDIA INJECTORS MARKET FOR DIAGNOSTIC IMAGING CENTERS, BY REGION, 2022–2029 (USD MILLION)
10 CONTRAST MEDIA INJECTORS MARKET, BY REGION
10.1 INTRODUCTION
TABLE 52 CONTRAST MEDIA INJECTORS MARKET, BY REGION, 2022–2029 (USD MILLION)
10.2 NORTH AMERICA
FIGURE 38 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
TABLE 53 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 54 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 55 NORTH AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 56 NORTH AMERICA: CONTRAST MEDIA INJECTORS CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 57 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 58 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 59 NORTH AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.2.1 NORTH AMERICA: RECESSION IMPACT
10.2.2 US
10.2.2.1 Rising adoption of technologically advanced products to drive market
TABLE 60 US: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 61 US: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 62 US: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.2.3 CANADA
10.2.3.1 Rising investments in medical imaging equipment to drive market
TABLE 63 CANADA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 64 CANADA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 65 CANADA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3 EUROPE
TABLE 66 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 67 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 68 EUROPE: CONTRAST MEDIA INJECTORS SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 69 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 70 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 71 EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.3.1 EUROPE: RECESSION IMPACT
10.3.2 GERMANY
10.3.2.1 Advancements in imaging technologies to fuel uptake
TABLE 72 GERMANY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 73 GERMANY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 74 GERMANY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.3 FRANCE
10.3.3.1 Increasing prevalence of cancer to propel market
TABLE 75 FRANCE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 76 FRANCE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 77 FRANCE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.4 UK
10.3.4.1 High incidence of CVD to propel market
TABLE 78 UK: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 79 UK: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 80 UK: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.5 ITALY
10.3.5.1 Rising incidence of chronic diseases to support market growth
TABLE 81 ITALY: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 82 ITALY: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 83 ITALY: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.6 SPAIN
10.3.6.1 Shortage of skilled radiologists to restrain market
TABLE 84 SPAIN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 85 SPAIN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 86 SPAIN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.3.7 REST OF EUROPE
TABLE 87 REST OF EUROPE: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 88 REST OF EUROPE: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 89 REST OF EUROPE: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4 ASIA PACIFIC
FIGURE 39 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET SNAPSHOT
TABLE 90 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 91 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 92 ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 93 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 94 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 95 ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.4.1 ASIA PACIFIC: RECESSION IMPACT
10.4.2 JAPAN
10.4.2.1 Rising geriatric population and subsequent increase in chronic diseases to drive market
TABLE 96 JAPAN: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 97 JAPAN: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 98 JAPAN: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.3 CHINA
10.4.3.1 Rising incidence of cancer and increasing establishment of hospitals to boost demand
TABLE 99 CHINA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 100 CHINA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 101 CHINA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.4 INDIA
10.4.4.1 Growing investments in radiology to propel market
TABLE 102 INDIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 103 INDIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 104 INDIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.5 AUSTRALIA
10.4.5.1 Increasing R&D investments for advanced diagnostic modalities to drive market
TABLE 105 AUSTRALIA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 106 AUSTRALIA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 AUSTRALIA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.6 SOUTH KOREA
10.4.6.1 Favorable reimbursements for diagnostic procedures to support market growth
TABLE 108 SOUTH KOREA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 109 SOUTH KOREA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 SOUTH KOREA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.4.7 REST OF ASIA PACIFIC
TABLE 111 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 112 REST OF ASIA PACIFIC: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 113 REST OF ASIA PACIFIC: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5 LATIN AMERICA
TABLE 114 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 115 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 116 LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 117 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 118 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 119 LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.5.1 LATIN AMERICA: RECESSION IMPACT
10.5.2 BRAZIL
10.5.2.1 Growing awareness of early disease detection & diagnosis to drive market
TABLE 120 BRAZIL: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 121 BRAZIL: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 122 BRAZIL: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5.3 MEXICO
10.5.3.1 Inadequate healthcare infrastructure to restrain market
TABLE 123 MEXICO: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 124 MEXICO: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 125 MEXICO: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.5.4 REST OF LATIN AMERICA
TABLE 126 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 127 REST OF LATIN AMERICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 128 REST OF LATIN AMERICA: CONTRAST MEDIA CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
10.6 MIDDLE EAST & AFRICA
10.6.1 IMPROVEMENTS IN HEALTHCARE INFRASTRUCTURE TO DRIVE MARKET
TABLE 129 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY PRODUCT, 2022–2029 (USD MILLION)
TABLE 130 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTOR SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 132 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 133 MIDDLE EAST & AFRICA: CONTRAST MEDIA INJECTORS MARKET, BY END USER, 2022–2029 (USD MILLION)
10.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT
11 COMPETITIVE LANDSCAPE
11.1 OVERVIEW
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
11.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET
TABLE 134 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
11.3 REVENUE ANALYSIS
FIGURE 40 REVENUE SHARE ANALYSIS OF TOP PLAYERS IN CONTRAST MEDIA INJECTORS MARKET (2019?2023)
11.4 MARKET SHARE ANALYSIS
FIGURE 41 MARKET SHARE ANALYSIS OF KEY PLAYERS (2023)
TABLE 135 CONTRAST MEDIA INJECTORS MARKET: DEGREE OF COMPETITION
11.4.1 RANKING OF KEY MARKET PLAYERS
FIGURE 42 RANKING OF KEY PLAYERS IN CONTRAST MEDIA INJECTORS MARKET, 2023
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
11.5.1 STARS
11.5.2 EMERGING LEADERS
11.5.3 PERVASIVE PLAYERS
11.5.4 PARTICIPANTS
FIGURE 43 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023
11.5.5.1 Company footprint
FIGURE 44 CONTRAST MEDIA INJECTORS MARKET: COMPANY FOOTPRINT
11.5.5.2 Product footprint
TABLE 136 CONTRAST MEDIA INJECTORS MARKET: PRODUCT FOOTPRINT
11.5.5.3 Application footprint
TABLE 137 CONTRAST MEDIA INJECTORS MARKET: APPLICATION FOOTPRINT
11.5.5.4 End-user footprint
TABLE 138 CONTRAST MEDIA INJECTORS MARKET: END-USER FOOTPRINT
11.5.5.5 Region footprint
TABLE 139 CONTRAST MEDIA INJECTORS MARKET: REGION FOOTPRINT
11.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
11.6.1 PROGRESSIVE COMPANIES
11.6.2 RESPONSIVE COMPANIES
11.6.3 DYNAMIC COMPANIES
11.6.4 STARTING BLOCKS
FIGURE 45 CONTRAST MEDIA INJECTORS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
11.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
TABLE 140 CONTRAST MEDIA INJECTORS MARKET: DETAILED LIST OF KEY STARTUP/SME PLAYERS
TABLE 141 CONTRAST MEDIA INJECTORS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
11.7 COMPANY VALUATION & FINANCIAL METRICS
11.7.1 FINANCIAL METRICS
FIGURE 46 EV/EBITDA OF KEY VENDORS
11.7.2 COMPANY VALUATION
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF KEY VENDORS
11.8 BRAND/PRODUCT COMPARISON
FIGURE 48 CONTRAST MEDIA INJECTORS MARKET: BRAND/PRODUCT COMPARISON ANALYSIS
11.9 COMPETITIVE SCENARIO
11.9.1 PRODUCT LAUNCHES & APPROVALS
TABLE 142 CONTRAST MEDIA INJECTORS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021–MAY 2024
11.9.2 DEALS
TABLE 143 CONTRAST MEDIA INJECTORS MARKET: DEALS, JANUARY 2021–MAY 2024
11.9.3 EXPANSIONS
TABLE 144 CONTRAST MEDIA INJECTORS MARKET: EXPANSIONS, JANUARY 2021–MAY 2024
12 COMPANY PROFILES
12.1 KEY PLAYERS
(Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats)*
12.1.1 BAYER AG
TABLE 145 BAYER AG: COMPANY OVERVIEW
FIGURE 49 BAYER AG: COMPANY SNAPSHOT (2023)
TABLE 146 BAYER AG: PRODUCTS OFFERED
TABLE 147 BAYER AG: DEALS, JANUARY 2021?MAY 2024
12.1.2 BRACCO IMAGING S.P.A.
TABLE 148 BRACCO IMAGING S.P.A.: COMPANY OVERVIEW
TABLE 149 BRACCO IMAGING S.P.A.: PRODUCTS OFFERED
TABLE 150 BRACCO IMAGING S.P.A.: DEALS, JANUARY 2021?MAY 2024
TABLE 151 BRACCO IMAGING S.P.A.: EXPANSIONS, JANUARY 2021?MAY 2024
12.1.3 GUERBET
TABLE 152 GUERBET: COMPANY OVERVIEW
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2023)
TABLE 153 GUERBET: PRODUCTS OFFERED
TABLE 154 GUERBET: PRODUCT LAUNCHES, JANUARY 2021?MAY 2024
12.1.4 ULRICH GMBH & CO. KG
TABLE 155 ULRICH GMBH & CO. KG: COMPANY OVERVIEW
TABLE 156 ULRICH GMBH & CO. KG: PRODUCTS OFFERED
TABLE 157 ULRICH GMBH & CO. KG: DEALS, JANUARY 2021?MAY 2024
12.1.5 MEDTRON AG
TABLE 158 MEDTRON AG.: COMPANY OVERVIEW
TABLE 159 MEDTRON AG: PRODUCTS OFFERED
TABLE 160 MEDTRON AG: DEALS, JANUARY 2021?MAY 2024
12.1.6 NEMOTO KYORINDO CO., LTD.
TABLE 161 NEMOTO KYORINDO CO., LTD.: COMPANY OVERVIEW
TABLE 162 NEMOTO KYORINDO CO., LTD.: PRODUCTS OFFERED
12.1.7 SHENZHEN ANKE HIGH-TECH CO., LTD.
TABLE 163 SHENZHEN ANKE HIGH-TECH CO., LTD.: COMPANY OVERVIEW
TABLE 164 SHENZHEN ANKE HIGH-TECH CO., LTD.: PRODUCTS OFFERED
12.1.8 SINO MDT
TABLE 165 SINO MDT: COMPANY OVERVIEW
TABLE 166 SINO MDT: PRODUCTS OFFERED
12.1.9 APOLLO RT CO., LTD.
TABLE 167 APOLLO RT CO., LTD.: COMPANY OVERVIEW
TABLE 168 APOLLO RT CO., LTD.: PRODUCTS OFFERED
12.1.10 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.
TABLE 169 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: COMPANY OVERVIEW
TABLE 170 SHENZHEN SEACROWN ELECTROMECHANICAL CO., LTD.: PRODUCTS OFFERED
12.1.11 SHENZHEN ANTMED CO., LTD.
TABLE 171 SHENZHEN ANTMED CO., LTD.: COMPANY OVERVIEW
TABLE 172 SHENZHEN ANTMED CO., LTD.: PRODUCTS OFFERED
12.1.12 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.
TABLE 173 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: COMPANY OVERVIEW
TABLE 174 SHENZHEN LNKMED MEDICAL TECHNOLOGY CO., LTD.: PRODUCTS OFFERED
12.1.13 UNION MEDICAL SHENZHEN CO., LTD.
TABLE 175 UNION MEDICAL SHENZHEN CO., LTD.: COMPANY OVERVIEW
TABLE 176 UNION MEDICAL SHENZHEN CO., LTD.: PRODUCTS OFFERED
12.1.14 SPECTRUM MEDICAL TECHNOLOGIES
TABLE 177 SPECTRUM MEDICAL TECHNOLOGIES: COMPANY OVERVIEW
TABLE 178 SPECTRUM MEDICAL TECHNOLOGIES: PRODUCTS OFFERED
12.1.15 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.
TABLE 179 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: COMPANY OVERVIEW
TABLE 180 SHENZHEN BOON MEDICAL SUPPLY CO., LTD.: PRODUCTS OFFERED
12.2 OTHER PLAYERS
12.2.1 SCW MEDICATH LTD.: COMPANY OVERVIEW
12.2.2 VYGON: COMPANY OVERVIEW
12.2.3 NANJING FOINOE CO., LTD.: COMPANY OVERVIEW
12.2.4 LEMER PAX: COMPANY OVERVIEW
12.2.5 COMECER S.P.A.: COMPANY OVERVIEW
12.2.6 TEMA SINERGIE S.P.A.: COMPANY OVERVIEW
12.2.7 SHEEN MAN CO., LTD.: COMPANY OVERVIEW
12.2.8 HONG KONG MEDI CO., LTD.: COMPANY OVERVIEW
12.2.9 QINGDAO HIPROVE MEDICAL TECHNOLOGIES CO., LTD.: COMPANY OVERVIEW
12.2.10 SHANGHAI KINDLY ENTERPRISE DEVELOPMENT GROUP CO., LTD: COMPANY OVERVIEW
*Details on Business overview, Products offered, Recent developments, MnM view, Key strengths, Strategic choices, and Weaknesses and Competitive threats might not be captured in case of unlisted companies.
13 APPENDIX
13.1 DISCUSSION GUIDE
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
13.3 CUSTOMIZATION OPTIONS
13.4 RELATED REPORTS
13.5 AUTHOR DETAILS
